Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neftel, K. A.
Right arrow Articles by Vorkauf, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neftel, K. A.
Right arrow Articles by Vorkauf, H.

Psychosomatic Medicine, Vol 44, Issue 5 461-469, Copyright © 1982 by American Psychosomatic Society

ORIGINAL ARTICLES

Stage fright in musicians: a model illustrating the effect of beta blockers

KA Neftel, RH Adler, L Kappeli, M Rossi, M Dolder, HE Kaser, HH Bruggesser and H Vorkauf

Stage fright was used to investigate the mode of action of beta blockers in acute anxiety and on the technical-motor performance of 22 performing string players. They received 100 mg of atenolol or placebo 6.5 hr before performing either in the presence or absence of an audience. Continuous heart rate, stage fright (especially devised rating scale), technical-motor performance (runs of fast notes, trills, vibratos), and urine catecholamine levels were assessed. Before an audience the placebo group showed a significant impairment of technical-motor performance (increase in the relative variance of repeated fast elements of movements: + 25.68%, p less than 0.01) as compared to performance with no audience present; there was a slight but not significant improvement under beta blockade (- 7.48%). Heart rate was significantly lower under beta blockade than under placebo (p less than 0.001). Urine catecholamine levels increased twice as much under beta blockade as under placebo before an audience (p less than 0.01). Beta blockade did not influence stage fright measured before performing, but reduced it (measured immediately after the concert) during the concert. We conclude that the drug was at least partially effective as shown by an improvement in technical-motor performance, and that the beneficial effects of beta blockade in stage fright only involve a peripheral site of action.


This article has been cited by other articles:


Home page
 Bulletin of Science Technology SocietyHome page
C. R. A. Aoki
Rewriting My Autobiography: The Legal and Ethical Implications of Memory-Dampening Agents
Bulletin of Science Technology Society, August 1, 2008; 28(4): 349 - 359.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
U. Muller, E. Mottweiler, and P. Bublak
Noradrenergic blockade and numeric working memory in humans
J Psychopharmacol, January 1, 2005; 19(1): 21 - 28.
[Abstract] [PDF]

Home page
 NEJMHome page
R. Michels and P. M. Marzuk
Progress in Psychiatry- Second of Two Parts
N. Engl. J. Med., August 26, 1993; 329(9): 628 - 638.
[Full Text]

Home page
 J PsychopharmacolHome page
P. Terry and P. Salmon
Biphasic effects of propranolol on a temporal generalization gradient in the rat
J Psychopharmacol, January 1, 1990; 4(2): 63 - 68.
[Abstract] [PDF]

Home page
 Psychology of MusicHome page
A. Steptoe
Stress, Coping and Stage Fright in Professional Musicians
Psychology of Music, April 1, 1989; 17(1): 3 - 11.
[Abstract]

Home page
 J PsychopharmacolHome page
P. Salmon
Biphasic effects of propranolol on extinction of rewarded responding
J Psychopharmacol, January 1, 1989; 3(2): 83 - 87.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Psychosomatic Society